Cholesterol drugs might boost kidney cancer survival
(HealthDay)—Cholesterol-lowering statin drugs that are taken by millions of Americans might also improve survival from a type of kidney cancer called renal cell carcinoma, a new study suggests.
Cancer
May 07, 2013 |
5 / 5 (1) |
0
Some prostate cancer patients more likely to die after weekend ER visits
Patients with prostate cancer that has metastasized, or spread, to other parts of the body face a significantly higher risk of dying when visiting a hospital emergency department on the weekend instead of on a weekday, according ...
Cancer
May 05, 2013 |
5 / 5 (1) |
0
Study finds experimental drug inhibits growth in all stages of common kidney cancer
Researchers at Mayo Clinic's campus in Florida have discovered a protein that is overly active in every human sample of kidney cancer they examined. They also found that an experimental drug designed to block the protein's ...
Cancer
Apr 30, 2013 |
not rated yet |
0
VEGF may not be relevant biomarker for advanced prostate cancer
The well-studied protein VEGF does not appear to have any prognostic or predictive value for men with locally advanced prostate cancer, researchers from the Department of Radiation Oncology at Thomas Jefferson University ...
Cancer
Apr 29, 2013 |
not rated yet |
0
Two-drug combination may slow deadly thyroid cancer
A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine. The two drugs togeth ...
Cancer
Jan 08, 2013 |
5 / 5 (1) |
0
|
Study shows potential new way to detect colorectal and other cancers
A unique new study led by University of Kentucky Markey Cancer Center researchers Guo-Min Li and Libya Gu, in collaboration with Dr. Wei Yang at National Institutes of Health, reveals a novel mechanism explaining the previously ...
Cancer
Apr 25, 2013 |
not rated yet |
0
Possible new therapy for the treatment of myeloma
(Medical Xpress)—Research from Karolinska Institutet shows that sorafenib, a drug used for advanced cancer of the kidneys and liver, could also be effective against multiple myeloma. The disease is one of the more common ...
Cancer
Sep 05, 2012 |
not rated yet |
0
|
Replicating risk genes in bipolar disorder
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies.
Psychology & Psychiatry
Oct 15, 2012 |
5 / 5 (3) |
0
Black patients with kidney cancer have poorer survival than whites
Among patients with the most common form of kidney cancer, whites consistently have a survival advantage over blacks, regardless of patient and tumor characteristics or surgical treatment. That is the conclusion of a new ...
Cancer
Nov 12, 2012 |
not rated yet |
0
Lead blood levels may increase smokers' risk for kidney cancer
Higher than normal levels of lead in the blood may signal a risk two times higher than average of developing renal cell carcinoma in smokers, according to medical researchers.
Cancer
Jan 23, 2012 |
not rated yet |
0
|
Biopsy-based algorithm found accurate for small renal masses
(HealthDay)—Compared with final pathology, biopsy of small renal masses (SRMs) can be accurately used in a treatment algorithm to direct management, according to research published in the February issue ...
Diseases, Conditions, Syndromes
Feb 09, 2013 |
not rated yet |
0
New compound holds high promise in battling kidney cancer
Chemists at the University of California, Riverside have developed a compound that holds much promise in the laboratory in fighting renal (kidney) cancer.
Cancer
Feb 19, 2013 |
1 / 5 (1) |
0
New hematuria risk index IDs patients at low cancer risk
(HealthDay)—A Hematuria Risk Index could identify cancer risk among patients with asymptomatic microscopic hematuria, according to a study published online Jan. 11 in the Mayo Clinic Proceedings.
Cancer
Jan 14, 2013 |
not rated yet |
0
New immune therapy shows promise in kidney cancer
An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.
Cancer
Jun 04, 2012 |
not rated yet |
0
Detecting tumour cells individually
(Medical Xpress) -- Swiss researchers have devised a method to detect mutations in tumor cells that are only present in a proportion of the cancer’s cells. The analysis reveals that cells of individual ...
Cancer
May 16, 2012 |
not rated yet |
0
|
